MR
Manjulata Rastogi
About Manjulata Rastogi
Data last updated:
Manjulata Rastogi is a Director at M.M. Remedies Private Limited (since 1998), Director at Das Drugs Private Limited (since 1998) and Director at Kant Drugs Private Limited (since 2025), and holds 1 more current directorship. The companies operate in Pharma and Business Services. The 3 current companies with reported revenue have a combined latest revenue of ₹187 Cr; the largest is M.M. Remedies Private Limited at ₹137 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 26 May 1998 | 1998 | ₹137 Cr (FY 2025) | Active | |
| Director | 01 Apr 1998 | 1997 | ₹38.25 Cr (FY 2025) | Active | |
| Director | 15 Dec 2025 | 2001 | ₹11.20 Cr (FY 2022) | Active | |
| Designated Partner | 01 Apr 2025 | 2014 | Active |
Board colleagues of Manjulata Rastogi
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manjulata Rastogi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manjulata Rastogi
Manjulata Rastogi currently holds 4 directorships: M.M. Remedies Private Limited (Director, since 26 May 1998, revenue ₹137 Cr (FY 2025)); Das Drugs Private Limited (Director, since 01 Apr 1998, revenue ₹38.25 Cr (FY 2025)); Kant Drugs Private Limited (Director, since 15 Dec 2025, revenue ₹11.20 Cr (FY 2022)); Kant Dealers Llp (Designated Partner, since 01 Apr 2025).
Manjulata Rastogi was first appointed on 01 Apr 1998 as Director at Das Drugs Private Limited. The most recent appointment on record is 15 Dec 2025 at Kant Drugs Private Limited.
The 3 current companies of Manjulata Rastogi that report revenue have a combined latest revenue of ₹187 Cr: M.M. Remedies Private Limited ₹137 Cr (FY 2025); Das Drugs Private Limited ₹38.25 Cr (FY 2025); Kant Drugs Private Limited ₹11.20 Cr (FY 2022).
The current boards of Manjulata Rastogi's companies include Anupama Rastogi (M.M. Remedies Private Limited), Anurag Das (M.M. Remedies Private Limited), Bharati Patwari Rastogi (M.M. Remedies Private Limited), Ekta Rastogi (M.M. Remedies Private Limited), Manoj Rastogi (M.M. Remedies Private Limited), Mehul Rastogi (M.M. Remedies Private Limited), among others.